Deutsche Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252M Buy
761,464
+49,489
+7% +$16.8M 0.08% 231
2025
Q4
$283M Buy
711,975
+105,655
+17% +$46.8M 0.09% 209
2025
Q3
$276M Sell
606,320
-42,964
-7% -$17.5M 0.09% 203
2025
Q2
$212M Buy
649,284
+72,291
+13% +$20M 0.08% 238
2025
Q1
$156M Buy
576,993
+20,414
+4% +$5.25M 0.06% 295
2024
Q4
$131M Buy
556,579
+17,308
+3% +$4.55M 0.05% 348
2024
Q3
$148M Buy
539,271
+50,153
+10% +$13.1M 0.06% 296
2024
Q2
$119M Sell
489,118
-17,959
-4% -$2.84M 0.05% 317
2024
Q1
$75.8M Buy
507,077
+44,758
+10% +$7.47M 0.04% 431
2023
Q4
$88.5M Sell
462,319
-537
-0.1% -$91.5K 0.05% 373
2023
Q3
$82M Sell
462,856
-24,020
-5% -$4.58M 0.05% 342
2023
Q2
$92.5M Buy
486,876
+27,310
+6% +$5.41M 0.05% 353
2023
Q1
$92.1M Sell
459,566
-5,487
-1% -$1.15M 0.05% 336
2022
Q4
$111M Buy
465,053
+211,369
+83% +$45.1M 0.06% 297
2022
Q3
$50.8M Buy
253,684
+6,437
+3% +$1.23M 0.03% 480
2022
Q2
$36.1M Sell
247,247
-34,863
-12% -$4.95M 0.02% 610
2022
Q1
$46.1M Buy
282,110
+7,462
+3% +$1.14M 0.02% 605
2021
Q4
$46.6M Sell
274,648
-7,514
-3% -$1.4M 0.02% 611
2021
Q3
$53.3M Buy
282,162
+17,319
+7% +$3.25M 0.03% 581
2021
Q2
$44.9M Buy
264,843
+6,261
+2% +$917K 0.02% 638
2021
Q1
$36.5M Sell
258,582
-34,685
-12% -$5.22M 0.02% 688
2020
Q4
$38.1M Buy
293,267
+5,761
+2% +$769K 0.02% 592
2020
Q3
$41.9M Buy
287,506
+1,416
+0.5% +$201K 0.03% 503
2020
Q2
$42.4M Sell
286,090
-6,553
-2% -$883K 0.03% 482
2020
Q1
$31.9M Buy
292,643
+11,423
+4% +$1.32M 0.03% 510
2019
Q4
$32.4M Sell
281,220
-374,410
-57% -$37.3M 0.02% 611
2019
Q3
$52.7M Sell
655,630
-100,511
-13% -$7.95M 0.04% 462
2019
Q2
$54.9M Buy
756,141
+299,860
+66% +$23M 0.03% 539
2019
Q1
$42.6M Buy
456,281
+256,013
+128% +$21.4M 0.03% 638
2018
Q4
$14.6M Sell
200,268
-104,328
-34% -$8.02M 0.01% 1072
2018
Q3
$26.7M Sell
304,596
-241,000
-44% -$24.2M 0.01% 972
2018
Q2
$53.7M Buy
545,596
+98,936
+22% +$9.81M 0.03% 632
2018
Q1
$53.2M Buy
446,660
+235,543
+112% +$30.4M 0.03% 625
2017
Q4
$26.8M Buy
211,117
+37,667
+22% +$4.73M 0.02% 835
2017
Q3
$20.4M Sell
173,450
-18,946
-10% -$1.62M 0.01% 1020
2017
Q2
$15.3M Sell
192,396
-15,571
-7% -$995K 0.01% 1112
2017
Q1
$10.7M Sell
207,967
-113,021
-35% -$5.22M 0.01% 1221
2016
Q4
$12M Sell
320,988
-75,236
-19% -$3.15M 0.01% 1144
2016
Q3
$26.9M Buy
396,224
+3,473
+0.9% +$245K 0.02% 772
2016
Q2
$21.8M Buy
392,751
+90,056
+30% +$5.67M 0.02% 879
2016
Q1
$19M Buy
302,695
+36,449
+14% +$2.42M 0.01% 923
2015
Q4
$25.1M Sell
266,246
-112,568
-30% -$10.4M 0.02% 830
2015
Q3
$30.4M Sell
378,814
-18,659
-5% -$2.07M 0.02% 677
2015
Q2
$47.6M Buy
397,473
+115,854
+41% +$13.8M 0.03% 556
2015
Q1
$29.4M Buy
281,619
+71,673
+34% +$7.26M 0.02% 755
2014
Q4
$20.4M Buy
209,946
+34,901
+20% +$3.23M 0.01% 992
2014
Q3
$13.7M Buy
175,045
+7,006
+4% +$452K 0.01% 1175
2014
Q2
$10.6M Sell
168,039
-86,932
-34% -$5.17M 0.01% 1330
2014
Q1
$17.1M Buy
254,971
+141,215
+124% +$10.9M 0.01% 1009
2013
Q4
$7.31M Sell
113,756
-52,993
-32% -$3.16M 0.01% 1518
2013
Q3
$10.7M Buy
166,749
+68,198
+69% +$3.4M 0.01% 1276
2013
Q2
$3.05M Buy
+98,551
New +$2.62M ﹤0.01% 1940

Other funds holding ALNY